Bristol Will Buy Diabetes Drug Maker

Bristol-Myers Squibb said it will buy diabetes drug maker Amylin in a $7 billion deal that will intensify the competition to treat the growing number of people afflicted with the disease.

ASK NEWS:
  • Half-year Report - London Stock Exchange
    ... individuals are forced to buy health ... Drug pricing is also on the ... stabilised for 2016. In diabetes, Sanofi ... the reporting period ...
    05/10/2016 - 5:49 am | View Link
  • More
BING NEWS:
  • Astra to Buy Stake in Diabetes Venture From Bristol for Up to $4.1 Billion
    Earlier this year, Bristol and AstraZeneca deepened their partnership by merging their diabetes-drug marketing teams. But sales at the diabetes venture, which was established in 2007 to develop the therapy Onglyza, have disappointed analysts. AstraZeneca ...
    12/19/2013 - 3:10 am | View Link
  • AstraZeneca to buy Bristol out of diabetes venture for up to $4.1 billion
    The move will bulk up AstraZeneca's thin drug portfolio and give Bristol ... Speculation that AstraZeneca might look to buy out Bristol was fuelled last month when the U.S.-based company decided to get out of diabetes research. The decision to quit ...
    12/18/2013 - 8:39 pm | View Link
  • AstraZeneca could buy Bristol stake in diabetes JV: analyst
    LONDON (Reuters) - AstraZeneca may seek to increase its stake in a diabetes joint venture with Bristol-Myers Squibb, following a decision by the U.S. firm to exit diabetes drug research, according to Citi. Bristol said on Thursday it would no longer ...
    11/7/2013 - 9:36 pm | View Link
  • Bristol-Myers Squibb Co. agrees to buy diabetes drugmaker
    NEW YORK — Bristol-Myers Squibb Co. agreed to buy diabetes drugmaker Amylin Pharmaceuticals for about $5 billion in cash, heating up the competition among drug producers to develop diabetes treatments. After the deal is complete, Bristol-Myers will enter ...
    07/1/2012 - 10:26 am | View Link
  • Bristol-Myers to buy diabetes drug maker for $5B
    (AP) — Drug maker Bristol-Myers Squibb Co. says it agreed to buy diabetes drug maker Amylin Pharmaceuticals for about $5 billion in cash. Bristol-Myers says it will pay $31 per share for Amylin in a cash tender offer. Including Amylin's debt and a ...
    07/1/2012 - 6:40 am | View Link
  • More
BING SEARCH:
  • Bristol-Myers to buy diabetes drug maker for $5B
    Bristol-Myers Squibb Co. agreed to buy diabetes drug maker Amylin Pharmaceuticals for about $5 billion in cash, heating up the competition among drugmakers ...
    07/1/2012 - 12:38 pm | View Website
  • Bristol-Myers to buy diabetes drug maker for $5B
    From Yahoo Finance: Bristol-Myers Squibb Co. agreed to buy diabetes drug maker Amylin Pharmaceuticals for about $5 billion in cash, heating up the ...
    07/1/2012 - 1:07 pm | View Website
  • Bristol Will Buy Diabetes Drug Maker
    Bristol Will Buy Diabetes Drug Maker WSJ June 30, 2012 By JONATHAN ROCKOFF Bristol-Myers Squibb Co. BMY +2.48% will buy diabetes drug maker Amylin Inc. in a $7 ...
    05/15/2016 - 8:15 pm | View Website
  • Bristol-Myers to buy diabetes drug maker for $5B
    After the deal is complete, Bristol-Myers will enter into an alliance with British drugmaker AstraZeneca to develop and commercialize Amylin's diabetes drugs.
    07/1/2012 - 1:07 pm | View Website
  • Bristol-Myers to buy diabetes drug maker for $5B
    (AP) — Drug maker Bristol-Myers Squibb Co. says it agreed to buy diabetes drug maker Amylin Pharmaceuticals for about $5 billion in cash.
    07/1/2012 - 1:36 pm | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News